NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation

por García-Carpizo, Verónica, Sarmentero, Jacinto, Han, Bomie, Graña, Osvaldo, Ruiz-Llorente, Sergio, Pisano, David G., Serrano, Manuel, Brooks, Harold B., Campbell, Robert M., Barrero, Maria J.
Publicado 2016

Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models

por Brooks, Harold B., Meier, Timothy I., Geeganage, Sandaruwan, Fales, Kevin R., Thrasher, Kenneth J., Konicek, Susan A., Spencer, Charles D., Thibodeaux, Stefan, Foreman, Robert T., Hui, Yu-Hua, Roth, Kenneth D., Qian, Yue-Wei, Wang, Tao, Luo, Shuang, Torrado, Alicia, Si, Chong, Toth, James L., Mc Cowan, Jefferson R., Frimpong, Kwame, Lee, Matthew R., Dally, Robert D., Shepherd, Timothy A., Durham, Timothy B., Wang, Yong, Wu, Zhipei, Iversen, Philip W., Njoroge, F. George
Publicado 2018